The fully double jabbed and boosted might want to check the fine print on their policies…
All rights reserved. You have permission to quote freely from the articles provided that the source (www.freewestmedia.com) is given.
An explosive case is currently being hotly debated on social media: In France, a rich, older entrepreneur from Paris is said to have died as a result of a Corona injection. Previously, he had taken out multi-million dollar life insurance policies for the benefit of his children and grandchildren, according to a media report.
Although vaccination is recognized as the cause of death by doctors and the insurance company, it has refused to pay out. The reason is because the side effects of the Corona jabs are known and published. They argue that the deceased took part in an experiment at his own risk. Covid-19 in itself is not classed as a “critical illness”.
According to the company, an experimental vaccination resulting in death is like suicide
The insurance company justified the refusal of payment to the family by stating that the use of experimental medication or treatments, including Corona injections, is expressly excluded from the insurance contract. The family’s subsequent lawsuit against the insurance company has been unsuccessful.
The court allegedly justified its ruling as follows: “The side effects of the experimental vaccine are published and the deceased could not claim to have known nothing about it when he voluntarily took the vaccine. There is no law or mandate in France that compelled him to be vaccinated. Hence his death is essentially suicide.” Since suicide is not covered by the policy from the outset, the insurance refuses to budge…
The refusal to pay for a vaccine-related death may not be surprising since globally the life insurance industry has been hit with reported claims of $5,5 billion in the first nine months of 2021 versus $3,5 billion for the whole of 2020, according to insurance broker Howden. Dutch insurer Aegon, with two-thirds of its business in the US, said its American claims in the third quarter were $111 million, up from $31 million a year earlier.